期刊文献+

Platelet-activating factor in liver injury: A relational scope 被引量:5

Platelet-activating factor in liver injury: A relational scope
下载PDF
导出
摘要 hepatocyte,肝的主要细胞的部件,到损害的不同类型的展览变量危险性由内长或外长的因素导致了。肝细胞机能障碍或死亡和新生依赖于在众多的生物学上活跃的分子之间的复杂相互作用。激活血小板的因素(PAF ) 似乎在临床、试验性的背景作为肝损伤的关键调停人起一个枢轴的作用,由它的受体对手的有益的效果暗示了。处于与肝损伤联系的条件的 PAF 的特定的功能、规章的性质的全面新概述在这评论被尝试。 The hepatocyte, the main cellular component of the liver, exhibits variable susceptibility to different types of injury induced by endogenous or exogenous factors. Hepatocellular dysfunction or death and regeneration are dependent upon the complicated interactions between numerous biologically active molecules. Platelet- activating factor (PAF) seems to play a pivotal role as the key mediator of liver injury in the clinical and experimental setting, as implied by the beneficial effects of its receptor antagonists. A comprehensive up-to-date overview of the specific functional and regulatory properties of PAF in conditions associated with liver injury is attempted in this review.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第23期3695-3706,共12页 世界胃肠病学杂志(英文版)
关键词 血小板活化因子 肝损伤 细胞再生 抗体 PAF PAF-R antagonists Liver Injury Regeneration
  • 相关文献

参考文献88

  • 1[1]Demopoulos CA,Pinckard RN,Hanahan DJ.Plateletactivating factor.Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl3-phosphorylcholine as the active component (a new class of lipid chemical mediators).J Biol Chem 1979; 254:9355-9358
  • 2[2]Pinckard RN,McManus LM,Demopoulos CA,Halonen M,Clark PO,Shaw JO,Kniker WT,Hanahan DJ.Molecular pathobiology of acetyl glyceryl ether phosphorylcholine:evidence for the structural and functional identity with plateletactivating factor.J Reticuloendothel Soc 1980; 28:95s-103s
  • 3[3]Stewart AG.Biological properties of platelet activating factor.In:Cunningham FM,ed.Lipid Mediators.London:Academic Press,1994:181-192
  • 4[4]Ishii S,Nagase T,Shimizu T.Platelet-activating factor receptor.Prostaglandins Other Lipid Mediat 2002; 68-69:599-609
  • 5[5]Chao W,Olson MS.Platelet-activating factor:receptors and signal transduction.Biochem J 1993; 292 (Pt 3):617-629
  • 6[6]Bratton D,Clay K,Henson P.Cellular sources of plateletactivating factor and related lipids.In:Cunningham FM,ed.Lipid Mediators.San Diego:Academic Press,1994:193-219
  • 7[7]Snyder F.Biosynthesis and catabolism of platelet activating factor.In:Cunningham FM,ed.The Handbook of Immunopharmacology.New York:Academic Press,1994:181-192
  • 8[8]Stafforini DM,Tjoelker LW.Human plasma platelet-activating factor acetylhydrolase.Methods Mol Bio11999; 109:49-58
  • 9[9]Tjoelker LW,Stafforini DM.Platelet-activating factor acetylhydrolases in health and disease.Biochim Biophys Acta 2000;1488:102-123
  • 10[10]Jaeschke H.Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning.Am J Physiol Gastrointest Liver Physiol 2003; 284:G15-26

同被引文献20

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部